Cinnamic Acid Composition for Chemotherapy-Induced Allodynia
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for allodynia caused by anticancer agents are ineffective and often interfere with the anticancer activity of these drugs, leading to prolonged pain and reduced efficacy.
Innovation Solution
A pharmaceutical composition containing cinnamic acid is used to prevent or treat allodynia, which includes administering cinnamic acid orally or intraperitoneally to subjects receiving or at risk of receiving anticancer agents.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If narcotic pain relievers are used to treat chronic pain, then pain relief is achieved, but side effects are strong making continuous use difficult
Solution Approach 1:
The patent employs cinnamic acid as a short-acting, naturally-derived compound that provides pain relief without the cumulative side effects of long-term narcotic use. The compound works acutely to reduce neuropathic pain and then allows natural pain pathways to recover, avoiding the dependency and tolerance issues associated with persistent narcotic administration.
Solution Approach 2:
Cinnamic acid acts as an intermediary substance that modulates the pain pathway without directly activating opioid receptors. It works through alternative mechanisms (likely involving TRP channels or other non-opioid pathways) to provide analgesia while bypassing the harmful side effect profile of traditional narcotics.
2Duration of action of stationary object
If nonsteroidal anti-inflammatory drugs are used to treat chronic pain, then continuous use is possible, but effects are weak
Solution Approach 1:
The patent changes the chemical parameter from conventional NSAIDs to cinnamic acid, which has different pharmacological properties. Cinnamic acid provides stronger analgesic effects for neuropathic pain through its unique mechanism of action while maintaining safety for continuous use, thus improving both effectiveness and duration simultaneously.
3Duration of action of stationary object
If tricyclic antidepressant or anti-epileptic drug are used to treat chronic pain, then continuous use is possible, but effects are weak
Solution Approach 1:
The patent uses cinnamic acid as a short-acting natural compound that provides acute pain relief and allows the nervous system to reset, rather than relying on long-term modulation by antidepressants or anti-epileptics. This approach achieves better pain control with fewer side effects.
4Object-affected harmful factors
If herbal extracts are used to inhibit side effects of anticancer agents, then side effects are reduced, but anticancer activity is interfered with
Solution Approach 1:
Cinnamic acid serves as a selective intermediary that specifically targets pain pathways without interfering with the anticancer mechanisms of chemotherapy agents. It modulates neuronal excitability and pain signal transmission while leaving cancer cell killing activities unaffected, thus resolving the contradiction between side effect management and treatment efficacy.
Data Source
Figure 1
Figure 2
Figure 3
AI summary
The present disclosure relates to a composition for preventing, alleviating, or treating allodynia caused by anticancer agents, containing cinnamic acid or a pharmaceutically acceptable salt thereof as an active ingredient. The composition of the present disclosure can prevent, alleviate, or treat allodynia by being administered to a subject scheduled to receive anticancer agents or having received anticancer agents.